<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Diabetes":1,
"Endoplasmic Reticulum Stress":1,
"Islet":1,
"Thyroid":9,
"Thyroid Hormone":1,
"Ovarian hyperstimulation":1,
"Positron emission tomography/computed tomography scan":1,
"Recombinant human thyrotropin":1,
"Rac1":1,
"adenocarcinoma":1,
"biopsy":2,
"invasion":3,
"miR-101":1,
"migration":2,
"thyroid cancer":12,
"Minimal invasive thyroid surgery":1,
"anterior mini insicion":1,
"thyriodectomy":1,
"thyroid disease":1,
"cosmetic issues":1,
"laser ablation":1,
"pressure symptoms":1,
"thyroid benign nodules":1,
"ultrasound-guided interventional procedures":1,
"Cancer stem cells":2,
"Eribulin":1,
"Fulvestrant":1,
"Tamoxifen":2,
"Adjuvant endocrine therapy":2,
"Disease-free survival (DFS)":1,
"Leuprorelin acetate":1,
"Premenopausal endocrine-responsive breast cancer":1,
"Safety":1,
"Anaplastic thyroid cancer":1,
"Cysteine-rich protein 61":1,
"Epidermal growth factor":1,
"KRAS":1,
"UbcH10":1,
"cetuximab":1,
"colorectal cancer":1,
"irinotecan":1,
"fine needle aspiration":3,
"kidney":1,
"malignancy":1,
"metastasis":2,
"needle core biopsy":1,
"nephrectomy":1,
"EZ-VANS":1,
"Endoscopic thyroidectomy":1,
"E·Z-access":1,
"Lap-protector":1,
"AZD1152":1,
"Aurora kinase inhibitors":1,
"Cell cycle":1,
"MLN8237":1,
"Medullary thyroid cancer":1,
"TT cell line":1,
"Adenoid cystic carcinoma":1,
"FISH":1,
"diagnosis":4,
"fluorescence PCR":1,
"prognosis":4,
"immunohistochemistry":6,
"papillary thyroid carcinoma":9,
"solid cell nest":1,
"thyroid remnants":1,
"Indeterminate cytology":1,
"Strain ratio":2,
"Thy3 thyroid nodules":1,
"Ultrasound":2,
"Ultrasound strain elastography":1,
"automation":1,
"biological markers":1,
"digital pathology":1,
"image analysis":1,
"reproducibility":1,
"contrast-enhanced ultrasonography":1,
"meta-analysis":2,
"thyroid nodules":2,
"Cadmium":1,
"Heavy metals":1,
"Trace elements":1,
"Zinc":1,
"breast cancer":8,
"cost-effectiveness":1,
"markov model":1,
"mastectomy":1,
"radiotherapy":4,
"Malignancy risk":1,
"Scoring system":1,
"Thyroid neoplasms":4,
"Thyroid nodule":4,
"Ultrasonography":3,
"Follow-up":1,
"Internet":1,
"Survivorship":1,
"Technology":1,
"Head and neck surgery":1,
"laryngeal cancer":1,
"reconstruction":1,
"chemotherapy":3,
"neoplasms":1,
"pregnancy":1,
"radiation therapy":2,
"NRAS oncogene":1,
"Thyroid neoplasm":3,
"cancer":9,
"dialysis":1,
"epidemiology and outcomes":1,
"kidney transplantation":1,
"FOXR2":1,
"Prognostic biomarker":1,
"Bleomicina":1,
"Bleomycin":1,
"Câncer de cabeça e pescoço":1,
"Electrochemotherapy":1,
"Eletroquimioterapia":1,
"Head and neck cancer":2,
"Palliative therapy":1,
"Terapia paliativa":1,
"Tireoide":1,
"Primary thyroid lymphoma":1,
"Ror2":1,
"Wnt5a":1,
"124I PET/CT":1,
"131I":1,
"differentiated thyroid cancer":3,
"radioactive iodine":2,
"Biomarker":2,
"Lymph node metastasis":1,
"lncRNA":1,
"AP-1":1,
"P85α":1,
"PDCD4":1,
"ROC curve":1,
"Tumorigenesis":1,
"Asian American":1,
"disparities":1,
"epidemiology":2,
"incidence":2,
"Molecular targets":1,
"Nanodevices":1,
"Radioiodine":1,
"Re-differentiation strategies":1,
"131I therapy":1,
"Taiwan National Health Insurance Database":1,
"BRAF":2,
"TIR3":1,
"cytology":1,
"expression analysis":1,
"Atypia of undetermined significance":2,
"cytopathology":1,
"follicular lesion of undetermined significance":1,
"Epithelial-mesenchymal transition":1,
"Salt-inducible kinase 1":1,
"Silencing mediator for retinoid":1,
"Thyroid receptors":1,
"Twist1":1,
"β-catenin":1,
"mRNA in situ hybridization":1,
"non-small cell lung cancer":1,
"thyroid transcription factor-1":1,
"tissue microarray":1,
"BRAF mutation test":1,
"DNA degradation":1,
"conventional smear":1,
"liquid-based cytology":1,
"Childhood radiation exposure":1,
"Paediatric thyroid carcinoma":1,
"BRAFV600E":1,
"MEK inhibition":1,
"cancer stem cell":2,
"microrna":3,
"pluripotency":1,
"resistance":2,
"3D endoscopy":1,
"Craniopharyngioma":1,
"Endoscopic endonasal surgery":1,
"Pituitary adenoma":1,
"Rathke cleft cyst":1,
"Transsphenoidal approach":1,
"ATA risk stratification":1,
"TNM staging":1,
"disease recurrence":1,
"disease-free survival":1,
"distant metastasis":1,
"Four-dimensional computed tomography":1,
"Hyperparathyroidism":1,
"Parathyroid adenoma":1,
"Volume":1,
"Chernobyl":1,
"Leukemia":1,
"Lymphoma":1,
"Solid cancer":1,
"Standardized Incidence Ratio (SIR)":1,
"Autoimmune diseases":1,
"Coeliac disease":1,
"Comorbidity":1,
"Bethesda category":1,
"Conventional subtype":1,
"Fine-needle aspiration":1,
"Differentiated thyroid carcinoma":3,
"ECM1":1,
"TMPRSS4":1,
"VDR":1,
"Psammoma body":1,
"Ultrasound fine-needle aspiration biopsy":1,
"von Kossa stain":1,
"Bethesda category III":1,
"malignancy rates for AUS/FLUS":1,
"repeat FNAB for initial AUS/FLUS category":1,
"intermediate-risk":1,
"radioactive iodine ablation":2,
"recurrence":3,
"proliferation":3,
"sphingosine-1-phosphate":1,
"Elastography":2,
"Hashimoto’s thyroiditis":1,
"Papillary thyroid microcarcinoma":1,
"TPO-Ab":1,
"National Program of Cancer Registries (NPCR)":1,
"North American Association of Central Cancer Registries (NAACCR)":1,
"Surveillance":1,
"and End Results (SEER)":1,
"liver cancer":1,
"mortality":2,
"survival":1,
"trends":1,
"viral hepatitis":1,
"Embolic agents":1,
"Embosphere":1,
"Hypervascular tumors":1,
"Transcatheter arterial embolization":1,
"Trisacryl gelatin microspheres":1,
"telomerase reverse transcriptase (TERT) promoter mutations":1,
"Hypothyroidism":1,
"Hereditary cancer":1,
"Mucocutaneous pigmentations":1,
"Peutz-Jeghers syndrome":1,
"Polyposis":1,
"STK11":1,
"DICER-1":1,
"Pleuropulmonary blastoma":1,
"Sertoli-Leydig cell tumor":1,
"Thyroid carcinoma":3,
"familial neoplasia":1,
"annual percent change":1,
"average annual percent change":1,
"delay adjustment":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"Goitre ovarien":1,
"Kyste ovaire":1,
"Ovarian cyst":1,
"Struma ovarii":1,
"Thyroïde":1,
"brain":1,
"breast":1,
"fluoroscopically guided interventional procedures":1,
"interventional radiology":1,
"radiologic procedures":1,
"Korea":1,
"attitudes":1,
"physician":1,
"second opinion":1,
"Contralateral carcinoma":1,
"Papillary microcarcinoma":1,
"Surgical strategy":1,
"Ablation":1,
"Nodule":1,
"Radiofrequency":1,
"Anaplastic thyroid carcinoma":2,
"Postoperative radiotherapy":1,
"Systematic review":1,
"Biological dosimetry":1,
"Cytogenetic damage in lymphocytes":1,
"Micronucleus assay":1,
"Radioiodine therapy":1,
"Virtual Touch tissue imaging":1,
"acoustic radiation force impulse":1,
"area ratio":1,
"head and neck ultrasound":1,
"sonography":1,
"Lung cancer":1,
"Pembrolizumab":1,
"Programmed death-ligand 1":2,
"U S Food and Drug Administration":1,
"BRCA1":1,
"methylation":1,
"pyrosequencing":1,
"Calcitriol":1,
"cancer stem-like cells":1,
"growth":1,
"ABI3":1,
"DNA methylation":1,
"NKX2-1":1,
"cancer-specific differentially methylated region (cDMR)":1,
"follicular thyroid carcinoma":2,
"medullary thyroid carcinoma":1,
"microRNA-375":1,
"treatment":1,
"vandetanib":1,
"Hypoxia":2,
"Stem cell niche":1,
"Stemness":1,
"ATF3":1,
"TR4":1,
"TR4 response element":1,
"hepatocellular carcinoma":3,
"OB3-leptin peptide":1,
"cancer cell invasion":1,
"leptin":1,
"obesity":1,
"Children":1,
"Neoplasia":1,
"Turner syndrome":1,
"X-chromosome":1,
"kinases":1,
"screening":1,
"siRNA":1,
"BER":1,
"Differentiated thyroid cancer risk":1,
"NER":1,
"Polymorphism":1,
"Undifferentiated thyroid carcinoma":1,
"VEGF":1,
"miR-126":1,
"Testicular cancer":1,
"genetics":1,
"clonal origin":1,
"exome sequencing":1,
"field cancerization":1,
"multifocality":1,
"papillary thyroid cancer":2,
"tumour evolution":1,
"diagnostic biomarker":1,
"growth factors":1,
"proNGF":1,
"CCR3":1,
"luminal-like":1,
"peritumoral":1,
"relapse-free survival":1,
"benign nodule":2,
"protein biomarkers":1,
"subcellular localization":1,
"gene expression profile":1,
"microenvironment":1,
"oncogenes":1,
"Neck dissection":1,
"complication":1,
"hypoparathyroidism":1,
"surgery":1,
"CK1α":1,
"DNA binding":1,
"MDMX":1,
"p53":1,
"secondary interaction":1,
"side population":1,
"metastases":1,
"Frozen section":1,
"HCC":1,
"PKM2":1,
"metabolism":1,
"CD147":1,
"CD326":1,
"CRC":1,
"BRAF V600E":1,
"KRAS G12D":1,
"kinase inhibitor":1,
"papillary thyroid cancer (PTC)":1,
"Apoptosis":2,
"miR-486-5p":1,
"Ablation techniques":1,
"Lymph nodes":1,
"Multidetector computed tomography":1,
"fluorodeoxyglucose-positron emission tomography/computed tomography":1,
"iodine-131(131I) whole body scintigraphy":1,
"radioiodine scan":1,
"Bethesda II":1,
"McGill Thyroid Nodule Score":1,
"Nodule size":1,
"Ultrasound-guided fine needle aspiration biopsy":1,
"ubiquitin-specific protease 22":1,
"EMT":1,
"LOX":1,
"bisphosphonates":1,
"chemoresistance":1,
"estrogen recepter":1,
"MEN1":1,
"MEN2":1,
"MEN4":1,
"Multiple endocrine neoplasia":1,
"Neuroendocrine tumor":1,
"Anthropometric parameters, thyroid function, biochemical parameter, chronic hepatitis C virus, non-response patients, chloroquine,":1,
"Lymph node neck dissection":1,
"Routine central lymph node dissection":1,
"Total thyroidectomy":1,
"Goserelin":1,
"Ovarian function suppression":1,
"Premenopause":1,
"Intramedullary spinal cord metastasis":1,
"laminectomy":1,
"spinal metastasis":1,
"anatomical resection":1,
"hepatectomy":1,
"intrahepatic recurrence":1,
"liver cirrhosis":1,
"nonanatomical resection":1,
"Microangiopathic hemolytic anemia (MAHA)":1,
"Thorombotic microangiopathy (TMA)":1,
"Dosimetry":1,
"Iodine radioisotopes/therapeutic use":1,
"Radioisotopes/pharmacokinetics":1,
"KDR":1,
"Lung adenocarcinoma":1,
"RET":1,
"Screening cascade":1,
"Selectivity":1,
"microcarcinoma":1,
"multifocal":1,
"Gefitinib":1,
"epidermal growth factor receptor (EGFR)":1,
"hepatocarcinogenesis":1,
"intraportal transplantation":1,
"head/neck":1,
"drug delivery systems":1,
"human thyroid carcinoma":1,
"nanoliposomes":1,
"phosphodiesterase-5 (PDE5) inhibitors":1,
"areola approach":1,
"endoscopic":1,
"thyroidectomy":1,
"Diffuse large B-cell lymphoma":1,
"Flow cytometry":1,
"Lymphocytic thyroiditis":1,
"MALT lymphoma":1,
"Thyroid lymphoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年5月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
